What You Should Know:
- Rhapsody, a digital health enablement company, announced the appointment of Jitin Asnaani as its new Chief Product Officer (CPO).
- Asnaani, a renowned expert in digital health and interoperability, brings a wealth of experience to lead the company's product strategy amidst an evolving healthcare landscape.
Read More
Spectral AI Appoints Peter M. Carlson as CEO
What You Should Know:
- Spectral AI, Inc. (Nasdaq: MDAI), a leader in AI-powered wound care diagnostics, announced key leadership changes and positive financial outlooks today.
- Peter M. Carlson assumes the role of Chief Executive Officer (CEO) and joins the Board of Directors. Mr. Carlson boasts a proven track record of driving growth and financial success for multiple public companies, including experience in the wound care industry.
- Wensheng Fan, after nearly four years as CEO,
Read More
WebMD Acquires Healthwise Assets to Strengthen Patient Education Offerings
What You Should Know:
- WebMD Health Corp., a provider of health information services, announced today the acquisition of certain operating assets from Healthwise, Inc., a company specializing in patient education and engagement solutions.
- Healthwise's assets, including its extensive library of patient education content, technology platform, and client relationships, will be integrated into WebMD Ignite, WebMD's healthcare engagement division.
Enhancing Patient Education and
Read More
Hippocratic AI Launches Beta Testing of First Generative AI for Healthcare
Healthcare Lags in AI Adoption Despite Potential Benefits, Study Reveals
What You Should Know:
- A recent study conducted by Access Partnership for Amazon Web Services (AWS) highlights a significant discrepancy between the perceived benefits of artificial intelligence (AI) in healthcare and the industry's current preparedness to utilize it effectively.
- The study underscores the need for collaboration between healthcare organizations and technology leaders like AWS to bridge the AI skills gap and unlock the full potential of AI in healthcare. This
Read More
GLP-1 Revolution, Non-Traditional Delivery, and Telehealth Expansion
The past few years have seen upheavals in healthcare, and 2024 so far shows no signs of breaking that pattern.
While the fundamentals of healthcare remain the same – caregivers treating patients – the who, how and where are changing, driven by shifting demographics, evolving consumer preferences, technological advancements and revolutionary drugs.
My work with clinicians in all 50 states, as well as the organizations that utilize their expertise, provides a unique lens to evaluate the
Read More
Philips Appoints Charlotte Hanneman as New CFO, Succeeding Abhijit Bhattacharya
What You Should Know:
- Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has announced the appointment of Charlotte Hanneman as its new Chief Financial Officer (CFO).
- Ms. Hanneman will join the company's Board of Management on June 1, 2024, officially assuming the CFO role on October 1, 2024. She will succeed Abhijit Bhattacharya, who will retire on September 30, 2024, after a successful 37-year career with Philips.
Hanneman's Bio/Background
Ms. Hanneman brings
Read More
Redi Health Secures $14M to Transform Patient Support Programs
What You Should Know:
- Redi Health, an innovator in digital health solutions, announced today the successful closing of a $14 million Series B funding round.
- The Series B round, led by Blue Heron Capital, with participation from North Coast Ventures and existing investors, empowers Redi Health to accelerate growth and further establish itself as a leader in the digital health space.
Addressing Challenges in Patient Support Programs
Traditional Patient Support Programs (PSPs)
Read More
Absci Announces $75M Public Offering to Fuel AI Drug Creation
What You Should Know:
- Absci Corporation (Nasdaq: ABSI), a company utilizing generative AI for drug discovery, announced today an initial public offering (IPO) of $75 million in common stock.
- This IPO aims to support the advancement of Absci's internal drug development programs, further investment in their Integrated Drug Creation™ platform, and general corporate purposes.
Offering Details
Absci intends to offer $75M of common stock, with an option to sell an additional $11.25M
Read More
Veradigm Acquires ScienceIO for $140M in Cash to Accelerate AI Innovation in Healthcare
What You Should Know:
- Veradigm Inc. (NASDAQ: MDRX), a provider of healthcare data and technology solutions, announced an agreement to acquire ScienceIO, a leader in healthcare AI platform and foundation models.
- The acquisition is valued at $140 million in cash, with $44 million deferred and payable in installments over three years. Veradigm will fund the transaction entirely from existing cash reserves.
Strategic Acquisition to Enhance AI Capabilities
This acquisition signifies
Read More
